Healthcare Equipment and Supplies
Company Overview of Lifeline Scientific, Inc.
Lifeline Scientific, Inc., a medical technology company, provides products and services for cell, tissue, and organ transplantation and research in the United States and internationally. It offers Lifeport Kidney Transporter, a medical device that provides enhanced kidney preservation, evaluation, and transport prior to transplantation. The company also provides single-use disposable products and organ preservation solutions. In addition, it is involved in the research and development of preservation technologies for transplantable biological materials; and scientific research for in vitro diagnostics, and allograft cells and tissues, such as heart valves, saphaneous veins, and cartilage and...
One Pierce Place
Itasca, IL 60143
Founded in 1998
Key Executives for Lifeline Scientific, Inc.
Lifeline Scientific, Inc. does not have any Key Executives recorded.
Lifeline Scientific, Inc. Key Developments
Lifeline Scientific, Inc. Provides Revenue Guidance for the Year Ended December 31, 2014
Feb 17 15
Lifeline Scientific, Inc. provided revenue guidance for the year ended December 31, 2014. For the period, the company expects revenues ahead of market expectations with total revenues for the period up 6% to USD 35.2 million compared to USD 33.2 million a year ago.
Lifeline Scientific, Inc. Announces Chinese Food and Drug Administration Approval for Clinical Organ Preservation and Flush Solutions for Commercial Sale to Hospitals in China
Feb 16 15
Lifeline Scientific, Inc. announced that the Chinese Food and Drug Administration (CFDA) have formally approved the company's clinical organ preservation and flush solutions, SPS-1® and KPS-1®, for commercial sale to hospitals within the People's Republic of China. KPS-1 is a specialty hypothermic machine perfusion solution that is used with the Company's proprietary LifePort® Kidney Transporter for machine preservation of donor kidneys indicated for transplantation. SPS-1 is a specialty hypothermic static preservation and flush solution indicated for pre-transplant flushing and static cold storage of abdominal donor organs, including kidneys, liver, pancreas, and small bowel. LifePort Kidney Transporter is currently used in many of China's transplant hospitals under clinical observation research protocols funded by China Health Ministry grants. It is reported that more than an estimated 1,000 LifePort preserved kidneys have been successfully transplanted in China during these studies. The LifePort Kidney Transporter and a suite of complementary single-use consumable products are in the final phase of regulatory review with the CFDA. The Company is encouraged that the recent CFDA approvals of its preservation solutions bodes well for these additional product approvals coming soon.
Lifeline Scientific, Inc. Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014
Sep 29 14
Lifeline Scientific, Inc. announced unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, the company's total net revenue was $15.1 million compared with $13.6 million a year ago. Loss from operations was $0.008 million compared with $1.44 million a year ago. Loss before income taxes was $0.06 million compared with $1.5 million a year ago. Net loss was $0.06 million compared with $1.41 million a year ago. Net income attributable to the company was $0.03 million compared with net loss of $1.3 million a year ago. Net cash provided by operating activities was $0.32 million compared with net cash used in operating activities of $1.77 million a year ago. Capital expenditures were $1.2 million compared with $0.45 million a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|